LGYRF yields 2.30% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, LGYRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LGYRF + JNJ for your $10,000?
Landis+Gyr Group AG, together with its subsidiaries, provides integrated energy management solutions to utility sector in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers prepayment electricity, commercial/industrial and grid, and non-smart and smart gas meters; heat and water meters and solutions; load control devices; and system deployment, managed network, and energy data management solutions. It also provides various advanced metering infrastructure offerings, including software, meter data management, installation, implementation, consulting, maintenance support, and related services; and develops and provides electronic devices for analyzing electricity usage in households. In addition, the company offers EV charging hardware and smart charging software comprising demand response and flexibility management, as well as cybersecurity solutions. The company was formerly known as Landis+Gyr Holding AG. Landis+Gyr Group AG was founded in 1896 and is headquartered in Cham, Switzerland.
Full LGYRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.